natgillin/translations-raw huggingface dataset:
For products in the same range, where the only difference among different products is the colouring agent, and that has no impact on safety, e.g. for lipsticks or other colour make-up, a combined product safety report may be considered, but is to be justified. 
For produkter på samme område, der den eneste forskjellen mellom forskjellige produkter er fargestoffet, og dette ikke påvirker sikkerheten, for eksempel for leppestift eller annen sminke, kan en kombinert sikkerhetsrapport for produktet vurderes, men den må begrunnes.
additional assessment of the safety of the formulated product, which cannot be assessed by assessing the substances/mixtures separately. 
ytterligere vurdering av sikkerheten til et sammensatt produkt, som ikke kan foretas ved å vurdere stoffene/stoffblandingene enkeltvis.
This could for instance be the formulation’s skin compatibility, assessment of possible combination effects, such as one ingredient that can increase the absorption rate of another ingredient, possible effects that could arise from interaction with packaging material, or possible effects due to chemical reactions between the individual substances/mixtures in the formulated product( ); 
Dette kan for eksempel dreie seg om sammensetningens forenlighet med bruk på huden, vurdering av mulige kombinasjonsvirkninger, for eksempel at én bestanddel kan øke absorpsjonsgraden til en annen bestanddel, mulige virkninger som kan oppstå fra interaksjon med emballasjemateriale, eller mulige virkninger som skyldes kjemiske reaksjoner mellom de enkelte stoffene/stoffblandingene i det sammensatte produktet( ),
SCCS, SCHER, SCENIHR, Toxicity and Assessment of Chemical Mixtures, 2012 http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_155.pdf 
SCCS, SCHER, SCENIHR, Toxicity and Assessment of Chemical Mixtures, 2012 http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_155.pdf
other factors that influence the safety assessment, such as stability, microbiological quality, packaging, and labelling, including use instructions and precautions for use. 
andre faktorer som påvirker sikkerhetsvurderingen, for eksempel stabilitet, mikrobiologisk kvalitet, emballasje og merking, herunder bruksanvisninger og forholdsregler for bruk.
The specific assessment for cosmetic products intended for use on children under the age of three which is required in accordance with Regulation (EC) No 1223/2009 should take into account the specific recommendations in the SCCS Notes of Guidance( ). 
Den spesifikke vurderingen av kosmetiske produkter beregnet på barn under tre år, som kreves i henhold til forordning (EF) nr. 1223/2009, bør ta hensyn til de særlige anbefalingene i SCCS Notes of Guidance( ).
SCCS Notes of Guidance, para 3-7.3, p. 51. 
SCCS Notes of Guidance, nr. 3-7.3, s. 51.
In the specific assessment required in accordance with Regulation (EC) No 1223/2009 for cosmetic products intended exclusively for use in external intimate hygiene, the particular characteristics of the application site also are to be taken into account. 
I den spesifikke vurderingen som kreves i samsvar med forordning (EF) nr. 1223/2009 for kosmetiske produktet beregnet utelukkende på bruk i forbindelse med utvortes intimhygiene, skal det også tas hensyn til særtrekkene på påføringsstedet.
A product that does not comply with Regulation (EC) No 1223/2009 is to be rejected and is not be marketed. 
Et produkt som ikke oppfyller kravene i forordning (EF) nr. 1223/2009, skal avvises, og det skal ikke markedsføres.
Recommendations by the safety assessor regarding the safe use of the product should be followed. 
Anbefalinger fra den sikkerhetssakkyndige om sikker bruk av produktet, skal følges.
In order to ensure that the cosmetic product safety report is kept up to date as required by Article 10(1)(c) of Regulation (EC) No 1223/2009, the safety of the finished product should be reassessed regularly. 
For å sikre at sikkerhetsrapporten for det kosmetiske produktet ajourføres i samsvar med artikkel 10 nr. 1 bokstav c) i forordning (EF) nr. 1223/2009, skal sikkerheten til det ferdige produktet vurderes på nytt regelmessig.
When changes in the legal requirements occur (e.g. restrictions of one of the substances included in the formulation), it should be checked, amongst others (e.g. labelling), whether the formulation still complies with the law, and the safety assessment should be reviewed and, if necessary, updated. 
Når de lovfestede kravene endres (for eksempel begrensninger for et stoff som inngår i sammensetningen), bør det blant annet (for eksempel med hensyn til merking) kontrolleres hvorvidt sammensetningen fortsatt er i samsvar med loven, og sikkerhetsvurderingen bør gjennomgås på nytt og om nødvendig ajourføres.
The safety assessment should also be reviewed and, if necessary, updated, where one or more of the following circumstances apply: 
Sikkerhetsvurderingen bør også gjennomgås på nytt og om nødvendig ajourføres i ett eller flere av følgende tilfeller:
new scientific findings and toxicological data on the substances are available which could modify the result of the existing safety assessment; 
det foreligger nye vitenskapelige konklusjoner og toksikologiske data om stoffer, som kan endre resultatet av den eksisterende sikkerhetsvurderingen,
changes occurring in the formulation or specifications of raw materials; 
det oppstår endringer i sammensetningen av eller spesifikasjonene for råstoffer,
changes occurring in the conditions of use; 
det oppstår endringer i bruksvilkårene,
a rising trend in terms of the nature, severity and frequency of undesirable effects, both under reasonably foreseeable conditions of use and in the case of misuse( ). 
det er en stigende tendens når det gjelder uønskede virkningers art, alvorlighetsgrad og hyppighet, både når produktet brukes under normale forhold og når det brukes feil( ).
Structures and processes should be established to ensure that the information relevant for the update of the cosmetic product safety report is efficiently exchanged between the responsible person and the safety assessor, and that the safety assessor is in a position to intervene where an update is necessary. 
Det bør utarbeides strukturer og prosesser for å sikre at de opplysningene som er relevante for ajourføringen av sikkerhetsrapporten for det kosmetiske produktet, utveksles i tilstrekkelig grad mellom den ansvarlige personen og den sikkerhetssakkyndige, og at den sikkerhetssakkyndige er i stand til å gripe inn dersom en ajourføring er nødvendig.
Assessor’s credentials and approval of Part B 
Sakkyndiges referanser og godkjenning av del B
The safety assessor is to be a professional with the necessary knowledge and expertise to draw up an accurate safety assessment, as indicated by the qualification requirements in Article 10(2) of Regulation (EC) No 1223/2009. 
Den sikkerhetssakkyndige skal ha den kunnskap og ekspertise som er nødvendig for å kunne utarbeide en nøyaktig sikkerhetsvurdering, som angitt i kvalifikasjonskravene i artikkel 10 nr. 2 i forordning (EF) nr. 1223/2009.
That section of the cosmetic product safety report aims at ensuring that this requirement is met and that the necessary evidence is provided. 
Dette avsnittet i sikkerhetsrapporten for det kosmetiske produktet sikter på å sikre at dette kravet blir oppfylt, og at nødvendig dokumentasjon framlegges.
That section of the safety report is required to list the name and address of the safety assessor and to be dated and signed. 
Det kreves at dette avsnittet i sikkerhetsrapporten viser den sikkerhetssakkyndige navn og adresse, og det skal være datert og underskrevet.
The result of the safety assessment is to be signed stating the date of preparation or be issued based on an electronic release establishing a clear relationship between the assessor, the formulation and the date of assessment. 
Resultatet av sikkerhetsvurderingen skal underskrives med angivelse av datoen den ble utarbeidet, eller utgis i elektronisk form, der det fastslås en klar forbindelse mellom den sakkyndige, sammensetningen og vurderingens dato.
The electronic version should be protected from abuse by unauthorised persons. 
Den elektroniske versjonen skal være beskyttet mot misbruk av uvedkommende personer.
In accordance with Article 10(2) of Regulation (EC) No 1223/2009, the safety assessor is required to be ‘a person in possession of a diploma or other evidence of formal qualifications awarded on completion of a university course of theoretical and practical study in pharmacy, toxicology, medicine or a similar discipline or a course recognised as equivalent by a Member State’. 
I samsvar med artikkel 10 nr. 2 i forordning (EF) nr. 1223/2009 skal den sikkerhetssakkyndige være «en person som innehar et diplom eller annet bevis på formell kvalifikasjon tildelt etter endt universitetsutdanning med teoretiske og praktiske studier i farmasi, toksikologi, medisin eller lignende fag, eller en utdanning som er anerkjent som likeverdig av en medlemsstat».
A person who has obtained qualifications in a third country may act as a safety assessor if they have completed ‘a course recognised as equivalent [to a university course of theoretical and practical study in pharmacy, toxicology, medicine or a similar discipline] by a Member State’. 
Personer som har oppnådd sine kvalifikasjoner i en tredjestat, kan fungere som sikkerhetssakkyndige, dersom de har fullført «en utdanning som er anerkjent som likeverdig [med universitetsutdanning med teoretiske og praktiske studier i farmasi, toksikologi, medisin eller lignende fag] av en medlemsstat».
Proof is to be provided of the safety assessor’s qualification (i.e. copy of the diploma and, where needed, proof of equivalence) laid down in Article 10 of Regulation (EC) No 1223/2009. 
Den sikkerhetssakkyndiges kvalifikasjoner skal dokumenteres (dvs. kopi av diplom, og dersom det er nødvendig, bevis for likeverdighet) fastsatt i artikkel 10 i forordning (EF) nr. 1223/2009.
References 
Henvisninger:
ATSDR (2004). 
ATSDR (2004).
Guidance Manual for the assessment of joint toxic action of chemical mixtures. 
Guidance Manual for the assessment of joint toxic action of chemical mixtures.
Atlanta, GA: 
Atlanta, GA:
ATSDR, U.S. Department of Health and Human Services, Public Health Service. 
ATSDR, U.S. Department of Health and Human Services, Public Health Service.
EFSA (2008) EFSA-Q-2006-160. 
EFSA (2008) EFSA-Q-2006-160.
Bremmer H.J., Prud’homme de Lodder L.C.H., van Engelen J.G.M., Cosmetics Fact Sheet to Assess the Risks for the Consumer, Updated version for ConsExpo 4, RIVM report 320104001/2006 (http://www.rivm.nl/bibliotheek/rapporten/320104001.pdf). 
Bremmer H.J., Prud’homme de Lodder L.C.H., van Engelen J.G.M., Cosmetics Fact Sheet to Assess the Risks for the Consumer, Updated version for ConsExpo 4, RIVM report 320104001/2006 (http://www.rivm.nl/bibliotheek/rapporten/320104001.pdf).
COSMED, Comment constituer le rapport de sécurité? 
COSMED, Comment constituer le rapport de sécurité?
(Règlement (CE) No 1223/2009), Collection: 
(Règlement (CE) No 1223/2009), Collection:
Les guides pratiques des entreprises — Editions 2011-2012., 
Les guides pratiques des entreprises — Editions 2011-2012.,
CTFA & COLIPA, Guidelines On Stability Testing Of Cosmetic Products, March 2004. 
CTFA & COLIPA, Guidelines On Stability Testing Of Cosmetic Products, March 2004.
European Chemicals Agency (ECHA), Guidance for identification and naming of substances under REACH and CLP, November 2011. 
European Chemicals Agency (ECHA), Guidance for identification and naming of substances under REACH and CLP, November 2011.
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment Chapter R.4: 
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment Chapter R.4:
Evaluation of available information, December 2011. 
Evaluation of available information, December 2011.
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment — Chapter R.7a: 
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment — Chapter R.7a:
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment — Chapter R.7c: 
European Chemicals Agency (ECHA), Guidance on information requirements and chemical safety assessment — Chapter R.7c:
ECHA, Practical guide 2: 
ECHA, Practical guide 2:
How to report weight of evidence’, 2010, http://echa.europa.eu/documents/10162/13655/pg_report_weight_of_evidence_en.pdf 
How to report weight of evidence’, 2010, http://echa.europa.eu/documents/10162/13655/pg_report_weight_of_evidence_en.pdf
European Commission, Communication from the Commission to the European Parliament and the Council on the animal testing and marketing ban and on the state of play in relation to alternative methods in the field of cosmetics, COM(2013) 135 final. 
Europakommisjonen, Melding fra Kommisjonen til europaparlamentet og rådet om forbud mot dyreforsøk og markedsføring, og om situasjonen med hensyn til alternative metoder på kosmetikksektoren, COM(2013) 135 endelig.
European Commission, Composition and undesirable effects of cosmetic products to be made easily accessible to the public — practical implementation of Article 7a(1)(h), second subparagraph, of Directive 76/768/EEC (http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/guide_access_info_en.pdf). 
European Commission, Composition and undesirable effects of cosmetic products to be made easily accessible to the public — practical implementation of Article 7a(1)(h), second subparagraph, of Directive 76/768/EEC (http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/guide_access_info_en.pdf).
Greim H. and Snyder R. (eds), Toxicology and Risk Assessment — A comprehensive Introduction. 
Greim H. and Snyder R. (eds), Toxicology and Risk Assessment — A comprehensive Introduction.
John Wiley & Sons Ltd, 2008. 
John Wiley & Sons Ltd, 2008.
Hall B., Tozer S., Safford B., Coroama M., Steiling W., Leneveu-Duchemin M.C., McNamara C. and Gibney M., European consumer exposure to cosmetic products, a framework for conducting population exposure assessments, Food and Chemical Toxicology, Volume 45, Issue 11, November 2007, Pages 2097-2108. 
Hall B., Tozer S., Safford B., Coroama M., Steiling W., Leneveu-Duchemin M.C., McNamara C. and Gibney M., European consumer exposure to cosmetic products, a framework for conducting population exposure assessments, Food and Chemical Toxicology, Volume 45, Issue 11, November 2007, side 2097-2108.
IGHRC 2006, Guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals. 
IGHRC 2006, Guidelines on route-to-route extrapolation of toxicity data when assessing health risks of chemicals.
Klimisch HJ, Andreae E and Tillmann U, A systematic approach for evaluating the quality of experimental and ecotoxicological data. 
Klimisch HJ, Andreae E and Tillmann U, A systematic approach for evaluating the quality of experimental and ecotoxicological data.
Regulatory Toxicology and Pharmacology 25 (1997), p. 1-5. 
Regulatory Toxicology and Pharmacology 25 (1997), s. 1-5.
Kroes R., Renwick A. G., Feron V., Galli C. L., Gibney M., Greim H., Guy R. H., Lhuguenot J. C., van de Sandt J. J. M., Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients, Food and Chemical Toxicology 45 (2007), 2533–2562. 
Kroes R., Renwick A. G., Feron V., Galli C. L., Gibney M., Greim H., Guy R. H., Lhuguenot J. C., van de Sandt J. J. M., Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients, Food and Chemical Toxicology 45 (2007), 2533–2562.
Loretz L.J., Api A.M., Babcock L., Barraj L.M., Burdick J., Cater K.C., Jarrett G., Mann S., Pan Y.H., Re T.A., Renskers K.J., Scrafford C.G., Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow, Food Chem Toxicol. 
Loretz L.J., Api A.M., Babcock L., Barraj L.M., Burdick J., Cater K.C., Jarrett G., Mann S., Pan Y.H., Re T.A., Renskers K.J., Scrafford C.G., Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow, Food Chem Toxicol.
2008 May; 46(5):1516-24, Epub 2007 Dec 23. 
2008 May; 46(5):1516-24, Epub 2007 Dec 23.
Mildau G., Burkhard A., Daphi-Weber J., Große-Damhues J., Jung J., Schuster B., Walther C., Basic Requirements for Safety Assessment of Cosmetic Products, SOFW Journal, 133 6-2007, pp. 16-22. 
Mildau G., Burkhard A., Daphi-Weber J., Große-Damhues J., Jung J., Schuster B., Walther C., Basic Requirements for Safety Assessment of Cosmetic Products, SOFW Journal, 133 6-2007, pp. 16-22.
Miljøstyrelsen, Guideline on Safety Assessment of Cosmetic Products, Environmental Guidelines No 10 2000. 
Miljøstyrelsen, Guideline on Safety Assessment of Cosmetic Products, Environmental Guidelines No 10 2000.
OECD (2007), Guidance on Grouping of Chemicals. 
OECD (2007), Guidance on Grouping of Chemicals.
Series on Testing and Assessment, No 80. 
Series on Testing and Assessment, No 80.
OECD (2009), Guidance Document for using the OECD (Q)SAR Application Toolbox to Develop Chemical Categories According to the OECD Guidance on Grouping of Chemicals. 
OECD (2009), Guidance Document for using the OECD (Q)SAR Application Toolbox to Develop Chemical Categories According to the OECD Guidance on Grouping of Chemicals.
Pauwels M., Rogiers V., Human Health Safety Evaluation of Cosmetics in the EU: 
M. Pauwels, V. Rogiers, Human Health Safety Evaluation of Cosmetics in the EU:
A Legally Imposed Challenge to Science, Toxicology and Applied Pharmacology, 243 (2010), pp. 260-274. 
A Legally Imposed Challenge to Science, Toxicology and Applied Pharmacology, 243 (2010), s. 260-274.
SCCS (Scientific Committee on Consumer Safety), Guidance on safety assessment of nanomaterials in cosmetics, SCCS/1484/12. 
SCCS (Scientific Committee on Consumer Safety), Guidance on safety assessment of nanomaterials in cosmetics, SCCS/1484/12.
SCCS, The SCCS’s Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, 8 th Revision, SCCS/1501/12. 
SCCS, The SCCS’s Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, 8 th Revision, SCCS/1501/12.
SCCS, SCHER and SCENIHR, Toxicity and Assessment of Chemical Mixtures, 2012. 
SCCS, SCHER and SCENIHR, Toxicity and Assessment of Chemical Mixtures, 2012.
SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Opinion on the scientific basis for the definition of the term ‘nanomaterial’, 8 December 2010. 
SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Opinion on the scientific basis for the definition of the term ‘nanomaterial’, 8 December 2010.
Workshop Report ‘Assessment of undesirable events in cosmetic market surveillance: 
Workshop Report ‘Assessment of undesirable events in cosmetic market surveillance:
Background, description and use of a causality assessment method in cosmetovigilance’, Regulatory Toxicology and Pharmacology 58 (2010) 349–353. 
Background, description and use of a causality assessment method in cosmetovigilance’, Regulatory Toxicology and Pharmacology 58 (2010) 349–353.
Known Databases Containing Toxicological Data on Substances Used in Cosmetics 
Kjente databaser som inneholder toksikologiske data om stoffer som brukes i kosmetiske produkter
ChemIDPlus Light — http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp 
ChemIDPlus Light — http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp
ChemIDPlus Advanced — http://chem.sis.nlm.nih.gov/chemidplus/ 
ChemIDPlus Advanced — http://chem.sis.nlm.nih.gov/chemidplus/
Cosmetics Europe Recommendations — https://www.cosmeticseurope.eu/publications-cosmetics-europe-association/recommendations.html 
Cosmetics Europe Recommendations — https://www.cosmeticseurope.eu/publications-cosmetics-europe-association/recommendations.html
IPCS Inchem — http://www.inchem.org/pages/jecfa.html 
IPCS Inchem — http://www.inchem.org/pages/jecfa.html
PubMed — http://www.ncbi.nlm.nih.gov/pubmed 
PubMed — http://www.ncbi.nlm.nih.gov/pubmed
ToxNet — http://toxnet.nlm.nih.gov/ 
ToxNet — http://toxnet.nlm.nih.gov/
____________________ 
____________________
amending Annex III to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products 
om endring av vedlegg III til europaparlaments- og rådsforordning (EF) nr. 1223/2009 om kosmetiske produkter
Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products( ), and in particular Article 31(1) thereof, 
under henvisning til europaparlaments- og rådsforordning (EF) nr. 1223/2009 av 30. november 2009 om kosmetiske produkter( ), særlig artikkel 31 nr. 1,
Following the publication of a scientific study in 2001, entitled ‘Use of permanent hair dyes and bladder cancer risk’, the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers, subsequently replaced by the Scientific Committee on Consumer Products (‘SCCP’), pursuant to Commission Decision 2004/210/EC of 3 March 2004 setting up Scientific Committees in the field of consumer safety, public health and the environment( ), concluded that the potential risks of the use of hair dyes were of concern. 
Etter offentliggjøringen av en vitenskapelig undersøkelse i 2001 med tittelen «Use of permanent hair dyes and bladder cancer risk» konkluderte Vitenskapskomiteen for kosmetiske produkter og for varer som ikke er næringsmidler beregnet på forbrukere, som i samsvar med kommisjonsavgjerd 2004/210/EF av 3. mars 2004 om skiping av vitskapsutval på områda forbrukartryggleik, folkehelse og miljø( ) senere ble erstattet med Vitenskapskomiteen for forbruksvarer («SCCP»), med at de potensielle risikoene ved bruk av hårfargingsmidler gav grunn til bekymring.
The SCCP, in its opinions, recommended that the Commission take further steps to control the use of hair dye substances. 
SCCP anbefalte i sine uttalelser at Kommisjonen treffer ytterligere tiltak for å kontrollere bruken av stoffer i hårfargingsmidler.
The SCCP further recommended an overall safety assessment strategy for hair dye substances including the requirements for testing substances used in hair dye products for their potential genotoxicity or mutagenicity. 
SCCP anbefalte dessuten en samlet strategi for sikkerhetsvurdering av stoffer som brukes i hårfargingsmidler, herunder krav til prøving av disse stoffenes potensielle genotoksisitet eller arvestoffskadelighet.
Following the opinions of the SCCP, the Commission agreed with Member States and stakeholders on an overall strategy to regulate substances used in hair dye products according to which the industry was required to submit files, containing updated scientific data on the safety of hair dye substances, for a risk assessment by the SCCP. 
I samsvar med uttalelser fra SCCP ble Kommisjonen, medlemsstatene og de berørte parter enige om en samlet strategi for lovregulering av stoffer som brukes i hårfargingsmidler, som krever at industrien framlegger dokumentasjon med ajourførte vitenskapelige data om slike stoffers sikkerhet, slik at SCCP kan foreta en risikovurdering.
The SCCP, subsequently replaced by the Scientific Committee on Consumer Safety (‘SCCS’) pursuant to Commission Decision 2008/721/EC of 5 August 2008 setting up an advisory structure of Scientific Committees and experts in the field of consumer safety, public health and the environment and repealing Decision 2004/210/EC( ), assessed the safety of individual substances for which updated files had been submitted by the industry. 
SCCP, som i samsvar med kommisjonsbeslutning 2008/721/EF av 5. august 2008 om opprettelse av en rådgivningsstruktur med vitenskapskomiteer og sakkyndige på området forbrukersikkerhet, folkehelse og miljø, og om oppheving av avgjerd 2004/210/EF( ), senere ble erstattet med Vitenskapskomiteen for forbrukersikkerhet («SCCS»), har vurdert sikkerheten for enkelte stoffer som industrien har framlagt ajourført dokumentasjon for.